When examining the clinical phenotypes of the CVID cohort, we found that serum zonulin and I-FABP levels were significantly elevated among patients with CVID regardless of the presence or absence of known enteropathy (Supplemental Figure 3, A and B). The gene discussed is FABP2; the disease is common variable immunodeficiency.